Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
72.3M
-
Shares change
-
-4.38M
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
-$107M
-
Put/Call ratio
-
2.24
-
Number of buys
-
80
-
Number of sells
-
-99
-
Price
-
$14.31
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2020
242 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2020.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.3M shares
of 93.1M outstanding shares and own 77.7% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.5M shares), BAILLIE GIFFORD & CO (8.97M shares), VANGUARD GROUP INC (8.37M shares), EARNEST PARTNERS LLC (4.16M shares), STATE STREET CORP (4.1M shares), DISCIPLINED GROWTH INVESTORS INC /MN (3.03M shares), DIMENSIONAL FUND ADVISORS LP (2.99M shares), D. E. Shaw & Co., Inc. (2.68M shares), Camber Capital Management LP (2.35M shares), and NORTHERN TRUST CORP (1.89M shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.